Shunjun Fu

Second Department of Hepatobiliary Surgery, Southern Medical University

Affiliated withSouthern Medical University

Research Area

Behavior Medicine

Biography

Shunjun Fu has not added Biography.
If you are Shunjun Fu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 1	2023
Publication title Cited by 1	2025

Other Publications

Article	Year
The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma. BMC cancer\| PubMed ID: 25880619	2015
A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotran... BMC cancer\| PubMed ID: 26907597	2016
Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma. BMC cancer\| PubMed ID: 30103712	2018
The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma. Molecular oncology\| PubMed ID: 30943320	2019
TBH score: a new model to predict and prevent severe liver damage after chemotherapy for cancer patients. Cancer management and research\| PubMed ID: 31372047	2019
Gelsolin Promotes Cancer Progression by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma and Correlates with a Poor Prognosis. Journal of oncology\| PubMed ID: 32377190	2020
TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients. Aging\| PubMed ID: 33177245	2020
Prognostic Value of Preoperative Serum Leucine Aminopeptidases in Hepatocellular Carcinoma Patients Who Underwent Liver Transplantation. Cancer management and research\| PubMed ID: 33574703	2021
Co-amplification of genes in chromosome 8q24: a robust prognostic marker in hepatocellular carcinoma. Journal of gastrointestinal oncology\| PubMed ID: 34295559	2021
Comparison of Hepatic Resection with Percutaneous Ablation for Hepatocellular Carcinoma in the Caudate Lobe Within Milan Criteria. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract\| PubMed ID: 34494218	2022
Intrahepatic Biliary Cystadenoma With Colonic Adenomatous Polyps in a Patient With Chronic Hepatitis B: A Case Report and Literature Review. Frontiers in medicine\| PubMed ID: 34977067	2021
Case Report: One-Year Delay in the Effect of Conversion Surgery Therapy for Advanced Hepatocellular Carcinoma After Systemic Therapy. Frontiers in molecular biosciences\| PubMed ID: 35187075	2021
Prediction of microvascular invasion in hepatocellular carcinoma with expert-inspiration and skeleton sharing deep learning. Liver international : official journal of the International Association for the Study of the Liver\| PubMed ID: 35319151	2022
Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combi... Frontiers in immunology\| PubMed ID: 36119069	2022
A new cell-free therapeutic strategy for liver regeneration: Human placental mesenchymal stem cell-derived extracellular vesicles. Journal of tissue engineering\| PubMed ID: 36313857	2022
Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection. Frontiers in oncology\| PubMed ID: 36959801	2023
Aberrant expression of circular RNA DHPR facilitates tumor growth and metastasis by regulating the RASGEF1B/RAS/MAPK axis in hepatocellular carcinoma. Cellular oncology (Dordrecht)\| PubMed ID: 37099250	2023
A N7-methylguanosine modified circular RNA, circIPP2A2, promotes malignant behaviors in hepatocellular carcinoma by serving as a scaffold in modulating the Hornerin/PI3K/AKT/GSK3β axis. Cell death & disease\| PubMed ID: 39616161	2024